Mark Carthy's Net Worth
-$3 Thousand
Who is Mark Carthy?
Mark Carthy does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Trubion Pharmaceuticals, Inc, Cyberkinetics Neurotechnology Systems, Inc., ACADIA PHARMACEUTICALS INC, Solexa, Inc., and REXAHN PHARMACEUTICALS, INC..
SEC CIK
Mark Carthy's CIK is 0001286397
Past Insider Trading and Trends
2014 was Mark Carthy's most active year for acquiring shares with 2 total transactions. Mark Carthy's most active month to acquire stocks was the month of May. 2006 saw Mark Carthy paying a total of $2,996.46 for 279 shares, this is the most they've acquired in one year.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Trubion Pharmaceuticals, Inc No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +5,180.19% | 2.16M |
—
|
—
| 2.2M |
Oct 23
| |||
Form 4
|
∞
| 41.61K |
$13.00 | $540,982.00 | 41.61K |
Oct 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Cyberkinetics Neurotechnology Systems, Inc. No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +8.58% | 833.33K |
$1.20 | $1,000,000.80 | 10.54M |
Oct 18
| |||
Form 4
| +34.69% | 2.5M |
$1.20 | $3,000,000.00 | 9.71M |
Sep 26
| |||
Form 4
| +4.62% | 318.5K |
$3.00 | $955,503.00 | 7.21M |
Nov 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ACADIA PHARMACEUTICALS INC (ACAD) Snapshot price: $16.07
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 29
| |||
Form 4
| +22.78% | 586.4K |
$6.82 | $4,000,023.96 | 3.16M |
Apr 20
| |||
Form 4
| +112.31% | 2.6M |
$7.00 | $1,995,000.00 | 4.91M |
Jun 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
REXAHN PHARMACEUTICALS, INC. (OCUP) Snapshot price: $1.2001
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Solexa, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 279 |
$10.74 | $2,996.46 | 279 |
Jan 13
| |||
Form 4
| +22.14% | 552.01K |
$4.00 |
—
| 3.05M |
Jul 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||